Liang C - Search Results

1

An interpretable machine learning prognostic system for locoregionally advanced nasopharyngeal carcinoma based on tumor burden features.

Chen X, Li Y, Li X, Cao X, Xiang Y, Xia W, Li J, Gao M, Sun Y, Liu K, Qiang M, Liang C, Miao J, Cai Z, Guo X, Li C, Xie G, Lv X. Chen X, et al. Among authors: liang c. Oral Oncol. 2021 Jul;118:105335. doi: 10.1016/j.oraloncology.2021.105335. Epub 2021 May 21. Oral Oncol. 2021. PMID: 34023742

2

A Prognostic Predictive System Based on Deep Learning for Locoregionally Advanced Nasopharyngeal Carcinoma.

Qiang M, Li C, Sun Y, Sun Y, Ke L, Xie C, Zhang T, Zou Y, Qiu W, Gao M, Li Y, Li X, Zhan Z, Liu K, Chen X, Liang C, Chen Q, Mai H, Xie G, Guo X, Lv X. Qiang M, et al. Among authors: liang c. J Natl Cancer Inst. 2021 May 4;113(5):606-615. doi: 10.1093/jnci/djaa149. J Natl Cancer Inst. 2021. PMID: 32970812 Free PMC article.

3

Prognostic and Treatment Guiding Significance of MRI-Based Tumor Burden Features and Nodal Necrosis in Nasopharyngeal Carcinoma.

Chen X, Cao X, Jing B, Xia W, Ke L, Xiang Y, Liu K, Qiang M, Liang C, Li J, Gao M, Li W, Miao J, Liu G, Cai Z, Lv S, Guo X, Li C, Lv X. Chen X, et al. Among authors: liang c. Front Oncol. 2020 Sep 11;10:537318. doi: 10.3389/fonc.2020.537318. eCollection 2020. Front Oncol. 2020. PMID: 33042831 Free PMC article.

4

Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical Trial.

Liu GY, Li WZ, Wang DS, Liang H, Lv X, Ye YF, Zhao C, Ke LR, Lv SH, Lu N, Bei WX, Cai ZC, Chen X, Liang CX, Guo X, Xia WX, Xiang YQ. Liu GY, et al. Among authors: liang cx, liang h. JAMA Oncol. 2022 Apr 1;8(4):553-561. doi: 10.1001/jamaoncol.2021.7366. JAMA Oncol. 2022. PMID: 35175316 Free PMC article. Clinical Trial.

5

Add-on individualizing prediction of nasopharyngeal carcinoma using deep-learning based on MRI: A multicentre, validation study.

Cao X, Chen X, Lin ZC, Liang CX, Huang YY, Cai ZC, Li JP, Gao MY, Mai HQ, Li CF, Guo X, Lyu X. Cao X, et al. iScience. 2022 Aug 3;25(9):104841. doi: 10.1016/j.isci.2022.104841. eCollection 2022 Sep 16. iScience. 2022. PMID: 36034225 Free PMC article.

6

Concurrent chemoradiotherapy combined with nimotuzumab in stage III-IVa nasopharyngeal carcinoma: a retrospective analysis.

Cai Z, Chen D, Qiu W, Liang C, Huang Y, Zhou J, Zhan Z, Xiang Y, Guo X, Lv X. Cai Z, et al. Among authors: liang c. J Cancer Res Clin Oncol. 2023 Jun;149(6):2327-2344. doi: 10.1007/s00432-022-04355-w. Epub 2022 Oct 27. J Cancer Res Clin Oncol. 2023. PMID: 36289067 Clinical Trial.

7

Integrated strategies for chemotherapy cycles in nasopharyngeal carcinoma patients: Real-world data from two epidemic centers guiding decision-making.

Zhan Z, Huang Y, Zhou J, Cai Z, Huang H, Deng Y, Qiu W, Cao X, Chen X, Liang C, Zhang L, Guo X, Yuan T, Lyu X. Zhan Z, et al. Among authors: liang c. Chin J Cancer Res. 2023 Apr 30;35(2):126-139. doi: 10.21147/j.issn.1000-9604.2023.02.04. Chin J Cancer Res. 2023. PMID: 37180835 Free PMC article.

8

Incidence, consequences, and predictors of serious chemotherapy-induced thrombocytopenia in nasopharyngeal carcinoma.

Zhang LL, Chen X, Huang YY, Liang CX, Qiang MY, Cai ZC, Zhan ZJ, Deng Y, Zhou JY, Huang HY, Guo X, Lv X. Zhang LL, et al. Cancer Med. 2023 Jul;12(13):14084-14093. doi: 10.1002/cam4.6062. Epub 2023 May 22. Cancer Med. 2023. PMID: 37212462 Free PMC article.

9

Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma.

Chen X, Li YX, Cao X, Qiang MY, Liang CX, Ke LR, Cai ZC, Huang YY, Zhan ZJ, Zhou JY, Deng Y, Zhang LL, Huang HY, Li X, Mei J, Xie GT, Guo X, Lv X. Chen X, et al. Lipids Health Dis. 2023 Jun 26;22(1):81. doi: 10.1186/s12944-023-01830-2. Lipids Health Dis. 2023. PMID: 37365637 Free PMC article.

10

Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial.

Cao X, Huang HY, Liang CX, Lin ZC, Zhou JY, Chen X, Huang YY, Zhan ZJ, Ke LR, Han LJ, Xia WX, Tang LQ, Guo SS, Liang H, Guo X, Lv X. Cao X, et al. Nat Commun. 2024 Jan 31;15(1):949. doi: 10.1038/s41467-024-45276-1. Nat Commun. 2024. PMID: 38297016 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,112 results

Search Page